Search results
No More Yearly Flu Shots? Vaccine Mixed From 80,000 Proteins Could Be The Key
IFLScience· 2 days agoA new vaccine strategy could spell the end of yearly flu shots, by targeting part of the virus that...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 1 day agoFurther, the company expects "higher vaccination uptake" in the U.S. if its updated Covid vaccine is...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 1 day agoIn its first-quarter earnings report, the Massachusetts-based biopharmaceutical company said its...
10 Shopping Strategies That Can Save Retirees Big Money At Costco
GOBankingRates via Yahoo Finance· 7 days agoAh, Costco! Land of the massive amounts of toilet paper and giant muffins! The mega-retailer is...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 2 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 1 day agoThat lines up with the seasonal market for Covid, flu and RSV. The company is hoping to gain FDA...
The Summer That COVID Went Away?
US News & World Report· 1 day agoThe milestone came and went with little fanfare. After more than four years with COVID-19, the Centers for Disease Control and Prevention recently...
Are your kids scared of needles? Health First helps remove pain, fear of getting a shot
Florida Today via Yahoo News· 2 days agoMcGregor said. “I don’t like needles even now.” Children who develop intense anxiety around “jabs”...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 3 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...